Viridian Therapeutics, Inc./DE Preferred Stock, Par or Stated Value Per Share
Viridian Therapeutics, Inc./DE (VRDN) had Preferred Stock, Par or Stated Value Per Share of $0.01 per share as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockParOrStatedValuePerShare · last filed 2026-02-26
- 2025-12-31: Preferred Stock, Par or Stated Value Per Share $0.01.
- 2025-09-30: Preferred Stock, Par or Stated Value Per Share $0.01.
- 2025-06-30: Preferred Stock, Par or Stated Value Per Share $0.01.
- 2025-03-31: Preferred Stock, Par or Stated Value Per Share $0.01.
| Period end | Preferred Stock, Par or Stated Value Per Share |
|---|---|
| 2025-12-31 | $0.01 10-K · filed 2026-02-26 |
| 2025-09-30 | $0.01 10-Q · filed 2025-11-05 |
| 2025-06-30 | $0.01 10-Q · filed 2025-08-06 |
| 2025-03-31 | $0.01 10-Q · filed 2025-05-06 |
| 2024-12-31 | $0.01 10-K · filed 2025-03-03 |
| 2024-09-30 | $0.01 10-Q · filed 2024-11-12 |
| 2024-06-30 | $0.01 10-Q · filed 2024-08-08 |
| 2024-03-31 | $0.01 10-Q · filed 2024-05-08 |
| 2023-12-31 | $0.01 10-K · filed 2024-02-27 |
| 2023-09-30 | $0.01 10-Q · filed 2023-11-13 |
| 2023-06-30 | $0.01 10-Q · filed 2023-08-08 |
| 2023-03-31 | $0.01 10-Q · filed 2023-05-10 |
| 2022-12-31 | $0.01 10-K · filed 2023-03-09 |
| 2022-09-30 | $0.01 10-Q · filed 2022-11-14 |
| 2022-06-30 | $0.01 10-Q · filed 2022-08-15 |
| 2022-03-31 | $0.01 10-Q · filed 2022-05-13 |
| 2021-06-30 | $0.01 10-Q · filed 2021-08-12 |
| 2021-03-31 | $0.01 10-Q · filed 2021-05-07 |
| 2021-01-04 | $0.01 10-K · filed 2022-03-11 |
| 2020-12-31 | $0.01 10-Q · filed 2021-08-12 |
| 2020-09-30 | $0.01 10-Q · filed 2020-11-12 |
| 2019-12-31 | $0.01 10-K · filed 2021-03-26 |
| 2019-09-30 | $0.01 10-Q · filed 2019-11-08 |
| 2019-06-30 | $0.01 10-Q · filed 2019-08-08 |
| 2019-03-31 | $0.01 10-Q · filed 2019-05-09 |
| 2018-12-31 | $0.01 10-K · filed 2019-03-14 |
| 2018-09-30 | $0.01 10-Q · filed 2018-11-07 |
| 2018-06-30 | $0.01 10-Q · filed 2018-08-08 |
| 2018-03-31 | $0.01 10-Q · filed 2018-05-09 |
| 2017-12-31 | $0.01 10-K · filed 2018-03-15 |
| 2017-09-30 | $0.01 10-Q · filed 2017-11-09 |
| 2017-06-30 | $0.01 10-Q · filed 2017-08-11 |
| 2017-03-31 | $0.01 10-Q · filed 2017-05-11 |
| 2016-12-31 | $0.01 10-K · filed 2017-03-24 |
| 2016-09-30 | $0.01 10-Q · filed 2016-10-26 |
| 2016-06-30 | $0.01 10-Q · filed 2016-08-15 |
| 2016-03-31 | $0.01 10-Q · filed 2016-05-16 |
| 2015-12-31 | $0.01 10-K · filed 2017-03-24 |
| 2015-09-30 | $0.01 10-Q · filed 2015-11-13 |
| 2015-06-30 | $0.01 10-Q · filed 2015-08-14 |
| 2015-03-31 | $0.01 10-Q · filed 2015-05-15 |
| 2014-12-31 | $0.01 10-K · filed 2016-03-21 |
| 2013-12-31 | $0.01 10-K · filed 2015-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |